Skip to main content

Euclidean Capital LLC

Position in SRZN — Surrozen, Inc./DE

CIK 1825034 NEW YORK, NY

Position in SRZN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,275,711
-$278,873 QoQ
Shares Held
258,529
0.0% QoQ
Ownership
2.20%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#24
of 69 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SRZN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Euclidean Capital LLC holds $27,571,414 across 6 Biotechnology names. SRZN ranks #5 (8.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 SRZN
Surrozen, Inc./DE
This page
258,529 $2,275,711

All Filings in SRZN

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 SRZNW 170,833
2026-06-30 $2,275,711 87,696
2026-03-31 SRZNW 170,833
2026-03-31 $2,554,584 87,696
2025-12-31 SRZNW 170,833
2025-12-31 $1,981,929 87,696
2025-09-30 SRZNW 170,833
2025-09-30 $1,129,962 87,696
2025-06-30 SRZNW 170,833
2025-06-30 $784,002 87,696
2025-03-31 SRZNW 170,833
2025-03-31 $1,022,535 87,696
2024-12-31 SRZNW 170,833
2024-12-31 $1,258,437 87,696
2024-09-30 SRZNW 170,833
2024-09-30 $1,050,598 87,696
2024-06-30 SRZNW 170,833
2024-06-30 $960,271 87,696
2024-03-31 SRZNW 170,833
2024-03-31 $1,377,704 87,696
2023-12-31 SRZNW 170,833
2023-12-31 $824,342 87,696
2023-09-30 SRZNW 170,833
2023-09-30 $393,451 802,963
2023-06-30 $441,629 802,963
2023-03-31 $483,383 802,963
2022-12-31 $467,324 802,963
2022-09-30 $1,621,985 802,963
2022-06-30 $2,408,889 802,963
2022-03-31 $2,416,918 802,963
2021-12-31 $5,171,088 802,964
2021-09-30 $5,684,992 802,965